Lei Zeng, MD

The Second Affiliated Hospital of Nanchang University

Nanchang, Jiangxi

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 28

176 - Efficacy and Safety of an Adaptive Treatment Strategy for Locoregionally Advanced Nasopharyngeal Carcinoma Based on Response Stratification to Nimotuzumab Plus Induction Chemotherapy: A Prospective Multicenter Phase II Clinical Study

11:35am - 11:45am ET